Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril for coronary microvascular dysfunction in women without obstructive coronary artery disease
2014-004490-17Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in microvascular angina (MVA) and Coronary Small Vessel Disease (CMD) comparing Ramipril with Placebo (2 arms). Primary endpoint: Coronary flow reserve after treatment. Started Oct 2014; status: completed.
02
Drugs
ramipril
03
Conditions
microvascular angina (MVA)Coronary Small Vessel Disease (CMD)
Beyond the preview
Go deeper on 2014-004490-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004490-17.